This article talks about the EMA’s(European Medical Agency’s) temporary updated guidance for the medicinal products manufacturers on GMP (Good Manufacturing Practices) and GDP (Good Distribution Practices) regulatory flexibilities for quick market entry of medicinal products during the Covid-19 pandemic.
voters
Report Story
Leave Your Comment